Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002352 · ClinicalTrials.gov registry record · NA
A Study of Lobucavir in Patients With AIDS
A NA study of HIV Infections and Cytomegalovirus Infections, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT00002352 is a NA study of HIV Infections and Cytomegalovirus Infections that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 30 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT00002352, a NA study of HIV Infections and Cytomegalovirus Infections, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS.
Conditions Studied
Interventions
- DRUG Lobucavir
Study Locations (3)
California
- Mount Zion Med Ctr / UCSF - San Francisco
- San Francisco Veterans Adm Med Cntr - San Francisco
Minnesota
- Univ of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002352
The ClinicalTrials.gov registry entry for NCT00002352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (93% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Lobucavir is the first listed.
NCT00002352 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00002352 about?
NCT00002352 is a clinical study titled "A Study of Lobucavir in Patients With AIDS". The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS.
What is the current status of trial NCT00002352?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants.
What conditions does trial NCT00002352 study?
This clinical trial studies the following conditions: HIV Infections, Cytomegalovirus Infections.
What interventions are being tested in trial NCT00002352?
The interventions under investigation include: Lobucavir (DRUG).
Who is sponsoring clinical trial NCT00002352?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002352 being conducted?
This trial has 3 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.